Baxter International Inc. (BAX)
Price:
24.27 USD
( - -0.06 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Becton, Dickinson and Company
VALUE SCORE:
6
2nd position
AptarGroup, Inc.
VALUE SCORE:
9
The best
ResMed Inc.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
NEWS
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
youtube.com
2025-08-01 08:31:00Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing globally, the future of gene therapy, changes at FDA, and more.
President Trump demands drugmakers slash prices within 60 days
youtube.com
2025-08-01 06:54:35CNBC's Joe Kernen reports on the latest news.
Baxter (BAX) Q2 Revenue Rises 4%
fool.com
2025-08-01 06:46:16Baxter (BAX) Q2 Revenue Rises 4%
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
zacks.com
2025-07-31 13:21:06Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
zacks.com
2025-07-31 12:41:17Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-07-31 12:21:34Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawrence H.
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com
2025-07-31 10:31:27While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
reuters.com
2025-07-31 09:32:24Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions.
Baxter Reports Second-Quarter 2025 Results
businesswire.com
2025-07-31 07:15:00DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter delivered performance in line with guidance while our employees across the globe continued advancing the company's life-sustaining Mission and building on its vision to redefine healthcare delivery,” said Brent Shafer, chair and interim CEO. “The company is poised to enter a new chapter with the appointmen.
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
zacks.com
2025-07-30 10:15:24Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
zacks.com
2025-07-28 13:46:11BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
businesswire.com
2025-07-23 06:00:00IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.
Baxter the Brave Mouse Unites Baxterville Against the Cat Pack
globenewswire.com
2025-07-22 11:00:00Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing. Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing.
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
businesswire.com
2025-07-17 16:15:00DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com.
Baxter Declares Quarterly Dividend
businesswire.com
2025-07-14 16:40:00DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
youtube.com
2025-08-01 08:31:00Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing globally, the future of gene therapy, changes at FDA, and more.
President Trump demands drugmakers slash prices within 60 days
youtube.com
2025-08-01 06:54:35CNBC's Joe Kernen reports on the latest news.
Baxter (BAX) Q2 Revenue Rises 4%
fool.com
2025-08-01 06:46:16Baxter (BAX) Q2 Revenue Rises 4%
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
zacks.com
2025-07-31 13:21:06Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
zacks.com
2025-07-31 12:41:17Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-07-31 12:21:34Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawrence H.
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com
2025-07-31 10:31:27While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
reuters.com
2025-07-31 09:32:24Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions.
Baxter Reports Second-Quarter 2025 Results
businesswire.com
2025-07-31 07:15:00DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter delivered performance in line with guidance while our employees across the globe continued advancing the company's life-sustaining Mission and building on its vision to redefine healthcare delivery,” said Brent Shafer, chair and interim CEO. “The company is poised to enter a new chapter with the appointmen.
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
zacks.com
2025-07-30 10:15:24Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
zacks.com
2025-07-28 13:46:11BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
businesswire.com
2025-07-23 06:00:00IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.
Baxter the Brave Mouse Unites Baxterville Against the Cat Pack
globenewswire.com
2025-07-22 11:00:00Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing. Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing.
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
businesswire.com
2025-07-17 16:15:00DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com.
Baxter Declares Quarterly Dividend
businesswire.com
2025-07-14 16:40:00DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in.